Quick Answer
IRONWOOD PHARMACEUTICALS INC reported Net Income of $24.02 million for fiscal year 2025.
IRONWOOD PHARMACEUTICALS INC Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | $24.02M | +2629.2% |
| 2024 | $880.0K | +100.1% |
| 2023 | -$1.00B | -672.5% |
| 2022 | $175.06M | -66.9% |
| 2021 | $528.45M | +397.7% |
| 2020 | $106.18M | +393.7% |
| 2019 | $21.50M | +107.6% |
| 2018 | -$282.37M | -141.5% |
| 2017 | -$116.94M | -43.1% |
| 2016 | -$81.71M | +42.7% |
| 2015 | -$142.67M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $40.08M | +999.3% | +69.8% |
| June 30, 2025 | $23.60M | +2844.1% | +163.1% |
| March 31, 2025 | -$37.39M | -798.3% | -1125.4% |
| September 30, 2024 | $3.65M | -76.2% | +524.0% |
| June 30, 2024 | -$860.0K | +99.9% | +79.3% |
| March 31, 2024 | -$4.16M | -109.1% | -127.2% |
| September 30, 2023 | $15.32M | -69.6% | +101.4% |
| June 30, 2023 | -$1.06B | -2964.6% | -2423.5% |
- IRONWOOD PHARMACEUTICALS INC showed an increase of +2629.2% in Net Income compared to the prior fiscal year.
- Over the 2015–2025 period, IRONWOOD PHARMACEUTICALS INC’s net income has grown by 116.8% (from -$142.67 million to $24.02 million).
- The most recent figure is from IRONWOOD PHARMACEUTICALS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: